| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-17 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-15 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-14 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.35 | 4e-12 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.32 | 6e-10 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |